BÜHLMANN at EuroMedLab 2019

Offering the broadest fecal calprotectin product portfolio

Calprotectin in IBD Diagnosis and Monitoring

Inflammatory Bowel Disease (IBD) include Crohn’s Disease (CD) and Ulcerative Colitis (UC), two incurable serious chronic diseases of the intestinal tract. IBD symptoms strongly resemble those of non-inflammatory diseases such as irritable bowel syndrome (IBS). Fecal calprotectin has proven itself as an excellent surrogate marker in IBD diagnosis and helps to reliably select patients for further invasive diagnostic procedures. Further, calprotectin in stool can also be used for disease monitoring in diagnosed patients since it correlates closely with mucosal healing. High calprotectin values are indicative for active inflammation in the gut, while moderate fecal calprotectin values can represent mild organic disease.

BÜHLMANN Highlights at EuroMedLab 2019

Impressions of the successful Educational Workshop at EuroMedLab 2019

The BÜHLMANN Educational Workshop at EuroMedLab 2019 about optimizing your lab workflow for fecal calprotectin testing was a great success. Fecal calprotectin shows an excellent clinical performance as a surrogate biomarker for the assessment of chronic intestinal inflammation as well as for the follow-up of diagnosed IBD patients for therapy guidance. The workflow of pre-analytics of stool samples as well as the analysis itself requires optimization to cope with strongly increasing test numbers. State of the art technologies combined with modern sample management strategies are the key for laboratories to measure up to the challenge.

CALEX® Cap Extraction Tutorial

CALEX® Cap on clinical chemistry analyser

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

The CALEX® Cap stool extraction device offers an efficient, convenient and hygienic extraction of stool samples and is fully compatible with total laboratory automation (TLA) solutions.

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

The BÜHLMANN fCAL® turbo in combination with the CALEX® Cap stool extraction device offers total laboratory automation (TLA) for fecal calprotectin testing.

BÜHLMANN Calprotectin Assays – From niche to full automation

BÜHLMANN is Gold Standard for IBD diagnosis and monitoring offering the largest product portfolio of calprotectin testing and TDM rapid tests for biologics in IBD. BÜHLMANN offers BÜHLMANN fCAL® turbo, the immuno turbidimetric fecal calprotectin assay for full automation, providing flexible and random access application on all major clinical chemistry platforms. The assay allows short turnaround time from the stool sample to the reportable result. The combination of the test with the CALEX® Cap extraction device strongly simplifies the cumbersome procedure for stool pre-analytics and is adapted to the use on clinical chemistry analysers. BÜHLMANN also offers the FDA cleared market leader BÜHLMANN fCAL® ELISA and the Quantum Blue® calprotectin rapid test.

CALEX® Cap extraction device offers an efficient, convenient and hygienic stool extraction. Its simple design makes it an ideal extraction device characterized not only by high safety but also by offering high stability of stool samples. Furthermore, the CALEX® Cap is fully compatible with total laboratory automation (TLA) solutions increasing the speed of sample processing and reducing hands-on time.

BÜHLMANN has recently introduced BÜHLMANN fCAL® turbo, the immuno turbidimetric fecal calprotectin assay. The technology of immunoturbidimetry implements a further milestone in fecal calprotectin quantification. It allows very rapid and flexible random access use, as well as being the ideal solution for high throughput applications in the routine laboratory. The assay can be applied on all automated platforms in clinical chemistry and allows short turnaround time from stool sample to reportable result.

BÜHLMANN has launched its first assay for fecal calprotectin testing more than 10 years ago and is today considered as the gold standard with the BÜHLMANN fCAL® ELISA. Two protocols are available with the BÜHLMANN fCAL® ELISA to cover different calprotectin ranges for IBD diagnosis and monitoring.

The BÜHLMANN Quantum Blue® rapid test combines the ease and speed of lateral flow technology, with full quantification by means of a small, telephone sized reading device. The Quantum Blue® reader provides a quantitative value within minutes and is therefore an ideal tool in a point-of-care setting. The BÜHLMANN product line offers three different fecal calprotectin test ranges suitable for IBD diagnosis and therapy follow-up of IBD patients. Besides calprotectin assays, BÜHLMANN offers the possibility for TDM for biologics in IBD as well as for CRP measurement on the Quantum Blue® reader.

Free WordPress Themes, Free Android Games